Omelia 40 mg/5 mg/12,5 mg filmom obložene tablete
| Name | Omelia 40 mg/5 mg/12,5 mg filmom obložene tablete |
|---|---|
| Marketing Authorisation Number | HR-H-029505255 |
| Active Substance | olmesartanmedoksomil amlodipinbesilat hidroklorotiazid |
| Composition | jedna filmom obložena tableta sadrži 40 mg olmesartanmedoksomila, 5 mg amlodipina (u obliku amlodipinbesilata) i 12,5 mg hidroklorotiazida |
| Pharmaceutical Form | filmom obložena tableta |
| Manufacturer | STADA Arzneimittel AG, Bad Vilbel, Njemačka Clonmel Healthcare Ltd., Clonmel, Co. Tipperary, Irska |
| Marketing Authorisation Holder | Stada d.o.o., Hercegovačka 14, Zagreb, Hrvatska |
| Marketing Authorisation Date | 05.12.2024 |
| MA Period of Validity | unlimited |
| Classification Number | UP/I-530-09/24-02/86 |
| Registration Number | 381-12-01/70-24-02 |
| Prescription | Medicinal product subject to medical prescription |
| Type of prescription | Medicinal product on medical prescription for renewable delivery |
| Distribution | Supply through pharmacies (community) |
| Advertising to general public | not allowed |
| ATC Code | C09DX03 |
| Marketing status | Marketed |
| Shortage status | No shortage |
| SmPC | download |
| PL | download |
| Public Assessment Report | download |
